(Q44222422)
Statements
1 reference
Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours (English)
1 reference
A Awada
1 reference
F A L M Eskens
1 reference
M Piccart
1 reference
D L Cutler
1 reference
A van der Gaast
1 reference
H Bleiberg
1 reference
J Wanders
1 reference
M N Faber
1 reference
P Statkevich
1 reference
P Fumoleau
1 reference
J Verweij
1 reference
EORTC Early Clinical Studies Group
1 reference
1 November 2002
1 reference
1 reference
Identifiers
1 reference